Our results demonstrate that N2-like neutrophils increase breast tumor cell viability (MDA-MB-231), which was not observed when neutrophils were stimulated with MCF10-EVs or MDA-EVs pre-treated with annexin-V (Figure 4A). This evidence concerns the gene ANXA5 and breast neoplasm.